Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J4U0 | ISIN: US6092071058 | Ticker-Symbol: KTF
Tradegate
17.01.25
21:46 Uhr
56,54 Euro
+0,22
+0,39 %
1-Jahres-Chart
MONDELEZ INTERNATIONAL INC Chart 1 Jahr
5-Tage-Chart
MONDELEZ INTERNATIONAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
56,2356,5117.01.
56,2656,3717.01.
ACCESS Newswire
533 Leser
Artikel bewerten:
(2)

Mondelez International: Mondelez 2022 Snacking Made Right Report: Leadership & Growth Culture

Finanznachrichten News

NORTHAMPTON, MA / ACCESSWIRE / January 24, 2024 / Mondelez 2022 Snacking Made Right Report

Building a winning culture across Mondelez International is one of the four strategic priorities at the core of our long-term business growth strategy. Culture is fundamental to building capacity for more sustainable business growth and unlocking operational excellence - enabling our strategic commitment to Snacking Made Right.

To support the acceleration of our growth, we are becoming more agile, digital, and local-consumer focused. We focus on attracting, developing and retaining deep and diverse talent, aim to build future growth capabilities and work to promote a thriving culture of engagement. We have given our local teams more autonomy to drive commercial and innovation plans as they are closer to the needs and desires of consumers. We will continue to leverage the efficiency and scale of our regional operating units while empowering our local and commercial operations to respond faster to changing consumer preferences and capitalize on growth opportunities.

Deep and Diverse Talent

We're continuing to invest in internal talent development - providing broad based and accelerated leadership development programs, early careers programming, mentoring, and on-the-job experiences and for colleagues across all levels. Our development programs equip our colleagues with future forward leadership competencies and capabilities with bespoke programs designed to accelerate high potential talents. Our early careers and new management trainee programs have provided next generation diverse talent with opportunities to gain experiences across functions. Further, mentoring programs continue to provide support to our top talent resulting in internal sufficiency and retention. All of these efforts continue to build a deep and diverse internal sustainable pipeline for the future.

Embedding Future Growth Capabilities

We're significantly upgrading commercial growth capabilities within our current and future leaders - to firmly establish Mondelez International as a leading digital and agile organization. Our approach includes creating integrated agile processes to drive simpler ways of working; launching a new General Manager Academy to advance commercial excellence; driving Revenue Growth Management capabilities and expertise in pricing; embedding digital learning and capability building across functions; and increasing local teams' exposure and expertise in driving strategic acquisition and integration activities.

Thriving and Engaged Organization

We want to remain an organization known for investing and building top talent - continuously developing, empowering and protecting the well-being of our people, while ensuring inclusivity. So, we have established a Flexible Working Pledge, and we're focusing on hybrid workplace solutions that encourage better work-life balance, attract a broader and more diverse workforce, reduce environmental impact, and improve productivity. In addition, our holistic employee well-being program is designed to address the changing needs of our colleagues across three key dimensions: Mind, Body and Connection. Through these and other initiatives, we aim to achieve top-tier engagement results on global benchmarks.

The 2022 EEO-1 report will be posted to mondelezinternational.com as it becomes available in line with EEO-1 submission.

" At Mondelez, we recognize that work is a social determinant of health and appreciate further that employee well-being is influenced by the workplace, from the physical environment to leadership and relationships with coworkers. That's why we are committed to cultivating a workplace that protects the health of our workforce and a culture that promotes overall well-being. We are laying a foundation to support our colleagues in their health journey and for them to thrive at work, at home and in the community. We aim to be inclusive and equitable in all our health-related endeavors. As a physician advocating for patients and workers, I understand that each individual's experience is unique and complex. In caring for our colleagues around the globe, we are purposefully taking a holistic approach to bring to life the 3 pillars of The Right You - Mind, Body, and Connection."

Anh T. Tran, MD, MPH, FACOEM

Global Health Sr. Director - HSE

Mondelez International

Read more in the Mondelez 2022 Snacking Made Right Report



View additional multimedia and more ESG storytelling from Mondelez International on 3blmedia.com.

Contact Info:
Spokesperson: Mondelez International
Website: https://www.3blmedia.com/profiles/mondelez-international
Email: info@3blmedia.com

SOURCE: Mondelez International



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.